3-D Matrix Stock

3-D Matrix Equity

The The Equity of 3-D Matrix (7777.T) as of Aug 13, 2026 is 2.22 B JPY. In the previous year, The Equity was 353.31 M JPY — a change of 527.27% (higher).

Equity

2.22 BJPY

YoY

527.27%

Last updated:

In 2026, 3-D Matrix's equity was 2.22 B JPY, a 527.27% increase from the 353.31 M JPY equity in the previous year.

Access this data via the Eulerpool API
Get Free API Key

3-D Matrix Stock analysis

What does 3-D Matrix do? 3-D Matrix Ltd is a company specialized in the development and manufacturing of innovative products in the field of biotechnology. Since its founding in 1998, the company has gained recognition for its outstanding research and development results and is now one of the leading companies in the industry. The history of 3-D Matrix Ltd began in 1998 when a group of scientists from Japan made a groundbreaking discovery in the field of materials science. They discovered that a certain material has a unique structure that allows cells and tissues to be cultivated in a more natural way than was previously possible. This discovery formed the basis for the founding of 3-D Matrix Ltd. The business model of 3-D Matrix Ltd is to use its innovative technology and unique products in various areas of biotechnology. The company's three main divisions are regenerative medicine, cell culture, and medical devices. In the field of regenerative medicine, 3-D Matrix Ltd is working to improve the healing of tissue damage and diseases. The company has developed a range of products that enable the effective and natural regeneration of the body's own cells and tissues. These products are used in the treatment of various diseases such as diabetes, arthritis, or tumors. In the cell culture division, 3-D Matrix Ltd offers products that enable cells to be cultured in a natural and effective way. The company has developed a range of innovative cell culture products that allow cells to be grown in a three-dimensional environment that closely resembles the natural environment in the body. These products are used in drug research and development, vaccine production, and personalized medicine. In the medical devices division, 3-D Matrix Ltd offers a range of products that are used in the performance of medical procedures. These products have been developed to improve the safety and effectiveness of medical procedures while reducing recovery time. These include products such as collagen membranes, collagen sponges, and brushes, which are used in plastic surgery, dentistry, and orthopedics. Some of the products offered by 3-D Matrix Ltd include collagen membranes, collagen sponges, collagen brushes, collagen fibrils, and collagen hydrogels. All of these products have been developed using 3-D Matrix Ltd's unique material technology and provide a natural and effective solution for a variety of medical applications. In conclusion, 3-D Matrix Ltd is a company dedicated to the development and manufacturing of innovative products in the field of biotechnology. The company has developed a unique technology that allows for the natural and effective cultivation and regeneration of cells and tissues. The products of 3-D Matrix Ltd are used in various areas of biotechnology, such as regenerative medicine, cell culture, and medical devices, and provide a natural and effective solution for a variety of medical applications. 3-D Matrix is one of the most popular companies on Eulerpool.

Equity Details

Analyzing 3-D Matrix's Equity

3-D Matrix's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding 3-D Matrix's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating 3-D Matrix's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

3-D Matrix's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in 3-D Matrix’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about 3-D Matrix stock

The Equity of 3-D Matrix is 2.22 B JPY in 2026.

The Equity of 3-D Matrix changed from 353.31 M JPY to 2.22 B JPY, representing a 527.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity 3-D Matrix since 2006 – with annual values, charts, and detailed analysis.

The Equity's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's 3-D Matrix historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — 3-D Matrix

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — 3-D Matrix